Company news
Impedimed Limited news in 2020
Impedimed Limited's news releases, calls and decks from 2020, newest first.
Meta-Analysis-BIS L-Dex Statistically Significant Reduction
November 29, 2020
ImpediMed Secures First Commercial Heart Failure Sales
November 17, 2020
AstraZeneca Selects SOZO for Second Large Renal Trial
November 9, 2020
Landmark Radiation Manuscript Supports L-Dex Use
October 28, 2020
Appendix 4C - Quarter ended 30 September 2020
October 26, 2020
AstraZeneca Selects SOZO for Heart Failure & Renal Trials
September 29, 2020
Appendix 4E for year ended 30 June 2020
August 25, 2020
Appendix 4C - Quarter ended 30 June 2020
July 27, 2020
Scripps Collaboration Preps SOZO for Heart Failure Launch
July 22, 2020
Response to ASX Price Query
May 22, 2020
ImpediMed Secures US Government COVID-19 CARES Act Loan
May 6, 2020
Completion of Retail Entitlement Offer
April 27, 2020
NSW Health Expands SOZO Use for Lymphoedema Prevention
April 20, 2020
Independent BIS RE-AIM Analysis to be Released at ASCO 2020
April 19, 2020
Change in substantial holding
April 16, 2020
Appendix 4C - Quarter ended 31 March 2020
April 15, 2020
ImpediMed Releases Heart Failure and Renal Disease Software
April 14, 2020
Successful Completion of $10m Institutional Portion of Offer
April 2, 2020
Prospectus
April 1, 2020
ImpediMed Secures Order from Large US Oncology Care Network
March 31, 2020
New National Purchasing Agreement for Lymphoedema Prevention
March 22, 2020
Baylor Scott & White Expands SOZO Use with New iOS Software
March 20, 2020
Appendix 4D and Interim Financial Report (Signed)
February 19, 2020
NCCN Guidelines for Breast Cancer Updated for Lymphoedema
February 9, 2020
Appendix 4C - Quarter ended 31 December 2019
January 21, 2020
Decks in 2020
- Investor Presentation (October 2020)
Investor deck · 38 slides · Oct 28, 2020
- Investor Presentation (September 2020)
Investor deck · 38 slides · Sep 10, 2020